A comprehensive evaluation of methods for Mendelian randomization using realistic simulations and an analysis of 38 biomarkers for risk of type 2 diabetes

被引:12
作者
Qi, Guanghao [1 ]
Chatterjee, Nilanjan [1 ,2 ]
机构
[1] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
关键词
Mendelian randomization; robust methods; comprehensive evaluation; simulation studies; biomarkers; type; 2; diabetes; COMPLEX DISEASES; PLEIOTROPY; HERITABILITY; INFERENCE;
D O I
10.1093/ije/dyaa262
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Previous studies have often evaluated methods for Mendelian randomization (MR) analysis based on simulations that do not adequately reflect the data-generating mechanisms in genome-wide association studies (GWAS) and there are often discrepancies in the performance of MR methods in simulations and real data sets. Methods: We use a simulation framework that generates data on full GWAS for two traits under a realistic model for effect-size distribution coherent with the heritability, coheritability and polygenicity typically observed for complex traits. We further use recent data generated from GWAS of 38 biomarkers in the UK Biobank and performed down sampling to investigate trends in estimates of causal effects of these biomarkers on the risk of type 2 diabetes (T2D). Results: Simulation studies show that weighted mode and MRMix are the only two methods that maintain the correct type I error rate in a diverse set of scenarios. Between the two methods, MRMix tends to be more powerful for larger GWAS whereas the opposite is true for smaller sample sizes. Among the other methods, random-effect IVW (inversevariance weighted method), MR-Robust and MR-RAPS (robust adjust profile score) tend to perform best in maintaining a low mean-squared error when the InSIDE assumption is satisfied, but can produce large bias when InSIDE is violated. In real-data analysis, some biomarkers showed major heterogeneity in estimates of their causal effects on the risk of T2D across the different methods and estimates from many methods trended in one direction with increasing sample size with patterns similar to those observed in simulation studies. Conclusion: The relative performance of different MR methods depends heavily on the sample sizes of the underlying GWAS, the proportion of valid instruments and the validity of the InSIDE assumption. Down-sampling analysis can be used in large GWAS for the possible detection of bias in the MR methods.
引用
收藏
页码:1335 / 1349
页数:15
相关论文
共 50 条
  • [41] Antioxidant Nutrients and Risk of Latent Autoimmune Diabetes in Adults and Type 2 Diabetes: A Swedish Case-Control Study and Mendelian Randomization Analysis
    Lampousi, Anna-Maria
    Lofvenborg, Josefin E.
    Ahlqvist, Emma
    Tuomi, Tiinamaija
    Wolk, Alicja
    Carlsson, Sofia
    NUTRIENTS, 2023, 15 (11)
  • [42] Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach
    Huang, Tao
    Ren, JingJing
    Huang, Jinyan
    Li, Duo
    BMC GENOMICS, 2013, 14
  • [43] Type 2 diabetes and fasting glycemic traits are causal factors of frozen shoulder: a 2-sample Mendelian randomization analysis
    Xu, Tianhao
    Xia, Qinghong
    Zhang, Lei
    Yang, Xiaolong
    Fu, Weili
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2024, 33 (02) : 399 - 408
  • [44] Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics
    Liu, Yi-Ying
    Zhang, Yue-Yang
    Wan, Qin
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [45] A diet-wide Mendelian randomization analysis: causal effects of dietary habits on type 2 diabetes
    Xiao, Rui
    Dong, Li
    Xie, Bo
    Liu, Beizhong
    FRONTIERS IN NUTRITION, 2024, 11
  • [46] Type 2 diabetes mellitus has a positive role in osteomyelitis: A Mendelian randomization analysis
    Fu, Ma
    Qi, Han
    Zhu, Suyue
    Zhu, Dongsheng
    Sun, Chao
    MEDICINE, 2024, 103 (39) : e39833
  • [47] Causal relationship between type 2 diabetes and glioblastoma: bidirectional Mendelian randomization analysis
    Chen, Wei
    Zhang, Taoyuan
    Zhang, Hui
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [48] Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study
    Soremekun, Opeyemi
    Karhunen, Ville
    He, Yiyan
    Rajasundaram, Skanda
    Liu, Bowen
    Gkatzionis, Apostolos
    Soremekun, Chisom
    Udosen, Brenda
    Musa, Hanan
    Silva, Sarah
    Kintu, Christopher
    Mayanja, Richard
    Nakabuye, Mariam
    Machipisa, Tafadzwa
    Mason, Amy
    Vujkovic, Marijana
    Zuber, Verena
    Soliman, Mahmoud
    Mugisha, Joseph
    Nash, Oyekanmi
    Kaleebu, Pontiano
    Nyirenda, Moffat
    Chikowore, Tinashe
    Nitsch, Dorothea
    Burgess, Stephen
    Gill, Dipender
    Fatumo, Segun
    EBIOMEDICINE, 2022, 78
  • [49] Novel Protein Biomarkers and Therapeutic Targets for Type 1 Diabetes and Its Complications: Insights from Summary-Data-Based Mendelian Randomization and Colocalization Analysis
    Zou, Mingrui
    Yang, Jichun
    PHARMACEUTICALS, 2024, 17 (06)
  • [50] Type 2 diabetes as a risk factor for promoting hypertrophic scar formation after wound healing: a two-sample mendelian randomization study
    Zheng, Wenlian
    Lai, Wenxiu
    Zhang, Yixun
    Wang, Xiaoxiang
    Yang, Kaibo
    Zhou, Xin
    Chen, Zheng
    Yang, Ronghua
    Deng, Liaoyuan
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)